Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more
Eden offers compounded semaglutide and tirzepatide at the same price for every dose. Here's an honest review of pricing, care model, and how it stacks up.
Eden keeps GLP-1 pricing simple: one all-inclusive monthly price that never moves with your dose. Compounded semaglutide is $99 per month and compounded tirzepatide is $129 per month, whether you're on the starting dose or the top of the ladder. Since September, Eden has dropped the separate $99 per month membership it charged on compounded medication, so those numbers are now the whole bill, and they're the lowest month-to-month compounded prices we track. Most providers escalate compounded pricing as your dose climbs, lock their best rate behind a year-long prepay, or add a membership on top; Eden's compounded program currently does none of the three. This review walks through Eden's pricing, care model, medication catalog, and where it fits versus closer peers.
Answer 10 questions and get a personalized recommendation.
Take the free quiz →Eden is an async telehealth platform built around two products: compounded semaglutide and compounded tirzepatide (not FDA-approved as finished products), both injectable, both sold at flat monthly rates that don't change as your dose escalates. Compounded medications use the same active ingredients as their brand-name counterparts but are prepared by state-licensed compounding pharmacies under different regulatory rules than mass-manufactured drugs (FDA, compounded drugs overview).
Eden's catalog also includes brand-name Wegovy and Zepbound, but at Eden's own cash price rather than manufacturer pricing: $1,695 per month for Wegovy and $1,399 per month for Zepbound, and the brand pathway still requires the $99 per month Eden Membership ($39 the first month) that Eden no longer charges on compounded medication. Those numbers sit close to full retail. Patients who want brand-name GLP-1s at a real discount are better served going directly through NovoCare (Wegovy from $149 per month) or LillyDirect (Zepbound from $299 per month) rather than Eden's brand pathway.
Care is intentionally light-touch. Free same-day consultation, free expedited shipping, 24/7 messaging with the care team, no scheduled coaching, no required lab work before prescribing. That last point cuts both ways depending on what you're looking for.
Prices below reflect Eden's own pricing pages as re-verified in October 2026 and may change.
| Medication | Medication price | Membership | Total (ongoing) | Notes |
|---|---|---|---|---|
| Compounded semaglutide | $99/mo | None | $99/mo | All-inclusive, same price at every dose |
| Compounded tirzepatide | $129/mo | None | $129/mo | All-inclusive, same price at every dose |
| Brand Wegovy (cash retail) | $1,695/mo | $99/mo ($39 first month) | ~$1,794/mo | Not a discount off NovoCare |
| Brand Zepbound (cash retail) | $1,399/mo | $99/mo ($39 first month) | ~$1,498/mo | Not a discount off LillyDirect |
A few things worth surfacing.
The flat dose-to-dose rate on compounded medications is unusual. At higher doses of tirzepatide, providers that escalate by dose can push $400 or more per month. Eden's tirzepatide stays at $129 per month no matter the dose. If you expect to maintain on a high dose long term, the math compounds in Eden's favor.
There's no commitment tier or membership to worry about either. Several competitors require a 12-month prepay to unlock their cheapest advertised price; Eden's $99 semaglutide and $129 tirzepatide prices apply whether you stay one month or twelve. Eden says these are not introductory rates and advertises a lifetime price guarantee (read its terms for what that covers). This is where the math changed most since our last review: through September, Eden charged $199 per month for tirzepatide and added a required $99 per month membership to both medications, for real totals of about $198 and $298 per month. With the membership gone and tirzepatide cut to $129, semaglutide costs half what it did and tirzepatide about $170 less.
On the brand side, Eden is not a price discount, and it's no longer priced anywhere near manufacturer parity either. Eden's cash price for brand Wegovy is $1,695 per month and Zepbound is $1,399 per month, both close to full retail and both still plus the $99 per month membership. Going directly through NovoCare (Wegovy from $149 per month) or LillyDirect (Zepbound from $299 per month) is dramatically cheaper for the same drug. Eden's brand pathway only makes sense if you specifically want everything handled through Eden's prescriber and don't mind paying well above the manufacturer-direct rate.
Eden
$99/mo compounded semaglutide or $129/mo tirzepatide, all-inclusive (no membership)
Same price at every dose for compounded semaglutide and tirzepatide. No membership fee and no multi-month commitment.
Eden's intake is streamlined. No routine pre-prescribing lab work is required, which is faster but less thorough than providers that build their care model around clinical oversight. For some patients that's fine. For patients with cardiac history, kidney concerns, a complicated medication list, or prior thyroid issues, a more thorough workup is worth the slower start. Talk to a licensed healthcare provider about whether your situation calls for labs before starting a GLP-1.
Support is minimal. There is no behavioral coaching layer, no scheduled video check-ins, no nutritionist included. If you want a structured program with weekly accountability, Eden is the wrong shape. If you want medication delivered with messaging support and otherwise to be left alone, the model fits.
State availability is the one piece of information Eden doesn't disclose cleanly on its public marketing pages. The Eden website lists 50-state coverage in its FAQs, but the actual confirmation happens at intake based on prescriber licensing in your state. Verify before paying.
Pros
Cons
The closest direct competitor is TrimRx. Both keep compounded pricing flat across doses with no separate membership and run a minimal-support care model, but Eden is now clearly the cheaper of the two. TrimRx lists $199 per month all-inclusive for compounded semaglutide and $349 per month for tirzepatide (the $179 figure on TrimRx's homepage is a first-month rate, and its lowest semaglutide rate, $174 per month, requires a 12-month prepay). Eden's $99 and $129 month-to-month prices undercut those by $100 and $220 per month. TrimRx's figures are from our September check; its site blocked our October check.
Oak Longevity is another compounded option, listed on its checkout menu at $133/month for semaglutide on a 3-month supply with its checkout code ($200/month without it), or $199/month for tirzepatide on the 3-month supply with the code ($250/month without it). Those are September figures; Oak's checkout menu could not be re-checked in October. Even Oak's best coded, prepaid rates sit above Eden's $99 and $129 month-to-month prices, and Oak's checkout FAQ says each dose step-up adds roughly $50 to $75, contradicting its "one price, all dosages" banner. On current numbers, Eden is cheaper than Oak at every dose.
Shed is another all-inclusive, no-membership compounded option: $159 per month for semaglutide and $239 per month for tirzepatide on its 12-month plan, or $199 and $299 month to month. Even with a year paid up front, Shed lands $60 to $110 per month above Eden. Shed's case is its broader menu of formats (microdose plans, lozenges, drops) rather than price.
Found is the alternative for buyers who want a broader catalog and structured support. Found's compounded plan bundles the membership into one price: $169 per month on a 12-month plan, or $289 per month month to month, with the medication included. Against Eden's new all-in prices, Found costs $70 more per month for semaglutide and $40 more for tirzepatide even on the 12-month plan, and $160 to $190 more month to month. Found also offers Foundayo (the oral Wegovy pill), brand-name Wegovy and Zepbound, and layers in coaching, a health coach, and a free insurance check that Eden doesn't offer. If you want that catalog breadth and coaching, that's what Found's premium buys; on price alone, Eden wins.
TrimRx
$199/mo compounded semaglutide, $349/mo tirzepatide (all-inclusive, no membership)
Flat all-inclusive pricing across doses, with no membership fee stacked on top.
Eden makes sense if you want compounded semaglutide or tirzepatide, you're comfortable with self-pay, and you want the lowest month-to-month price we track, with pricing that won't escalate as your dose climbs. There's no commitment, so the first month works as a test rather than a lock-in, and with no membership fee on compounded medication, the advertised price is the actual price.
Eden also offers brand-name Wegovy or Zepbound in the same checkout if you don't want to manage a manufacturer self-pay pathway yourself. But at $1,695 and $1,399 per month respectively, plus the $99 per month membership, you're paying well above NovoCare's or LillyDirect's direct pricing for that convenience, not getting a discount on the brand.
If you want a structured coaching program with weekly accountability, Eden isn't built for that. Found is better shaped for that buyer.
If you want a non-injectable compounded format, such as sublingual tablets, lozenges, or drops, Eden's compounded catalog is injectable-only. Henry Meds and Shed offer those formats, at higher prices.
If you have a medically complex situation that calls for thorough pre-prescribing workup, an insurance-first provider that handles labs and prior authorizations is a better fit.
If your insurance covers Wegovy or Zepbound directly, going through your existing primary care provider or an insurance-first telehealth option will almost always beat self-pay through any platform.
Eden's edge used to be structural: flat dose-to-dose pricing and no multi-month commitment, in a market where the headline number rarely matches the long-term reality. As of October it's price too. With the separate membership gone from its compounded program, $99 per month for semaglutide and $129 per month for tirzepatide is the whole bill, at every dose, month to month, and both are the lowest month-to-month compounded prices we track. Eden says these aren't introductory rates; we re-verify pricing monthly and will update this review if that changes. The old math still applies to brand-name Wegovy and Zepbound, which remain near cash retail plus the $99 per month membership.
The trade-off is care depth. No labs, no coaching, async-only support. If you want medication delivered cleanly and otherwise to be left alone, Eden delivers. If you want a clinical relationship, look elsewhere. For a deeper look at how compounded and brand-name options compare, our compounded vs brand-name semaglutide guide covers the regulatory and clinical differences.
Eden
$99/mo compounded semaglutide or $129/mo tirzepatide, all-inclusive (no membership)
Flat all-in pricing on compounded semaglutide and tirzepatide at every dose. No membership, no multi-month commitment, free same-day consultation.